Curated News
By: NewsRamp Editorial Staff
March 11, 2026
Catalyst Crew Appoints Dr. Kevin Rodan Levy as CEO for AI Healthcare Push
TLDR
- Catalyst Crew Technologies appoints Dr. Kevin Rodan Levy as CEO to lead its strategic transition into AI healthcare solutions, offering investors early access to emerging market opportunities.
- Dr. Kevin Rodan Levy was appointed CEO of Catalyst Crew Technologies on February 17, 2026, following a leadership transition disclosed in SEC Form 8-K filings.
- Catalyst Crew Technologies' new AI healthcare focus aims to improve access and efficiency in emerging markets through scalable digital health solutions.
- A doctor with clinical and tech platform experience now leads Catalyst Crew Technologies as it pivots to AI-driven healthcare for Latin America.
Impact - Why it Matters
This leadership transition signals a major strategic shift for Catalyst Crew Technologies toward AI-enabled healthcare solutions in emerging markets, particularly Latin America. As healthcare systems worldwide face increasing pressure to improve access and efficiency, especially in underserved regions, the company's focus on telehealth infrastructure, remote monitoring, and data analytics addresses critical gaps in healthcare delivery. Dr. Rodan's combined clinical and technology experience positions the company to potentially transform how healthcare is delivered in markets where traditional infrastructure is lacking. For investors, this represents a high-risk, high-potential opportunity in the growing digital health sector, while for healthcare consumers in emerging markets, it could mean improved access to quality care through innovative technology solutions.
Summary
Catalyst Crew Technologies Corp. (OTC: CCTC), an artificial intelligence-driven healthcare technology company, has announced a significant leadership transition as it advances its strategic shift toward AI-enabled healthcare solutions. Effective February 17, 2026, Dr. Kevin Rodan Levy has been appointed as Chief Executive Officer, President, Chief Financial Officer, Secretary, Treasurer, and Sole Director, following the resignation of the company's prior officers and directors as disclosed in a Form 8-K filed with the U.S. Securities and Exchange Commission. This leadership change marks a pivotal moment for the company as it executes its transformation from its previous business model to focus on scalable digital health platforms for emerging markets, with initial emphasis on Latin America.
Dr. Rodan brings a unique combination of clinical medical training, healthcare operations experience, and technology platform leadership to his new role. Since 2021, he has served as CEO of Grupo Casamed 18 C.A., where he managed healthcare delivery and organizational development initiatives, and has also led EmpleUp, a technology-focused human capital and recruitment platform. His background aligns perfectly with Catalyst Crew's new direction toward developing telehealth infrastructure, remote patient monitoring systems, healthcare data analytics, and integrated digital care platforms designed to improve access, efficiency, and care coordination in underserved markets.
In his statement, Dr. Rodan emphasized disciplined execution of the company's strategic transition, with particular focus on scalable platforms that address access and efficiency challenges in emerging markets. The company is building an integrated healthcare technology platform through technology development initiatives, strategic partnerships, and targeted acquisitions to meet growing demand for modernized healthcare delivery systems. Investors can access official filings through the U.S. Securities and Exchange Commission website at www.sec.gov, and the original release is available on www.newmediawire.com, where the company continues to provide updates through regulatory filings and public disclosures as it advances its AI-enabled healthcare transformation.
Source Statement
This curated news summary relied on content disributed by NewMediaWire. Read the original source here, Catalyst Crew Appoints Dr. Kevin Rodan Levy as CEO for AI Healthcare Push
